Announcement

Collapse
No announcement yet.

Original Antigenic Sin: Friend or Foe in Developing a Broadly Cross-Reactive Vaccine to Influenza?

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Original Antigenic Sin: Friend or Foe in Developing a Broadly Cross-Reactive Vaccine to Influenza?

    Cell Host Microbe. 2019 Mar 13;25(3):354-355. doi: 10.1016/j.chom.2019.02.009.
    Original Antigenic Sin: Friend or Foe in Developing a Broadly Cross-Reactive Vaccine to Influenza?

    Devarajan P1, Swain SL2.
    Author information

    Abstract

    In this issue of Cell Host & Microbe, two articles (Lee et al., 2019; Henry et al., 2019) find the influenza-specific antibody repertoire in humans becomes static over time and with age, despite repeated exposures. Identified persistent dominant clones target conserved viral epitopes, supporting the feasibility of a universal influenza vaccine.
    Copyright ? 2019 Elsevier Inc. All rights reserved.


    PMID: 30870620 DOI: 10.1016/j.chom.2019.02.009
Working...
X